Shield Therapeutics is a commercial stage specialty pharmaceutical company with a focus on addressing iron deficiency (ID) with its lead product ACCRUFeR® (ferric maltol), a novel, stable, non-salt based oral therapy for adults with ID/IDA. Visit accrufer.com for the product label and to learn more.